Successful treatment of thyrotoxicosis is accompanied by a decrease in serum sclerostin levels
<p>Abstract</p> <p>Sclerostin, a product of a <it>SOST</it> gene, is a protein expressed by osteocytes that inhibits osteoblastic bone formation. Several hormones, including PTH and glucocorticosteroids, have been suggested to be possible regulators of sclerostin produc...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-11-01
|
Series: | Thyroid Research |
Online Access: | http://www.thyroidresearchjournal.com/content/5/1/14 |